Overview

Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Colorectal cancer patients with metastases (mCRC) at response under first-line chemotherapy are candidates for an convenient maintenance treatment.
Phase:
N/A
Details
Lead Sponsor:
Beijing Chao Yang Hospital
Treatments:
Capecitabine